(Pro)renin receptor and vacuolar H+-ATPase

Keio Journal of Medicine

Volumn 61, Issue 3, 2012, Pages 73-78

  Ichihara, Atsuhiro ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Renin angiotensin system; Signal transduction; V ATPase; Vesicular acidification

Indexed keywords

LYSOSOME ENZYME; MESSENGER RNA; PRORENIN RECEPTOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; RENIN; UNCLASSIFIED DRUG; VACUOLAR HYDROGEN TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ACID SECRETION; CELL FUNCTION; CELL FUSION; CELL MEMBRANE; CELLULAR DISTRIBUTION; DIABETES MELLITUS; EMBRYONIC STEM CELL; ENDOCYTOSIS; ENZYME ACTIVATION; GENE; GENE LOCUS; HUMAN; HYPERTENSION; INTRACELLULAR SIGNALING; MUTATION; NONHUMAN; PHENOTYPE; PROTEIN PROCESSING; PROTEIN TARGETING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TRANSLATIONAL RESEARCH; X CHROMOSOME;

ANIMALS; HUMANS; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CELL SURFACE; RENIN; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84867691102     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.61.73     Document Type: Review

References (41)

1. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109: 1417-1427. [Medline]
2. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, Koura Y, Nishiyama A, Okada H, Uddin MN, Nabi AH, Ishida Y, Inagami T, Saruta T: Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest 2004; 114: 1128-1135. [Medline]
3. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Nakagawa T, Nishiyama A, Kawachi H, Shimizu F, Inagami T: Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 2006; 17: 2495-2503. [Medline] [CrossRef]
4. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T, Nishiyama A, Inagami T, Hayashi M: Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006; 47: 894-900. [Medline] [CrossRef]
5. Ichihara A, Suzuki F, Nakagawa T, Kaneshiro Y, Takemitsu T, Sakoda M, Nabi AH, Nishiyama A, Sugaya T, Hayashi M, Inagami T: Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 2006; 17: 1950-1961. [Medline] [CrossRef]
6. +-ATPase assembly in murine cardiomyocytes. Circ Res 2010; 107: 30-34. [Medline] [CrossRef]
7. Cruciat CM, Ohkawara B, Acebron SP, Karaulanov E, Reinhard C, Ingelfinger D, Boutros M, Niehrs C: Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. Science 2010; 327: 459-463. [Medline] [CrossRef]
8. Daneman D, Crompton CH, Balfe JW, Sochett EB, Chatzilias A, Cotter BR, Osmond DH: Plasma prorenin as an early marker of nephropathy in diabetic (IDDM) adolescents. Kidney Int 1994; 46: 1154-1159. [Medline] [CrossRef]
9. Deinum J, Ronn B, Mathiesen E, Derkx FH, Hop WC, Schalekamp MA: Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia 1999; 42: 1006-1010. [Medline] [CrossRef]
10. Deinum J, Tarnow L, van Gool JM, de Bruin RA, Derkx FH, Schalekamp MA, Parving HH: Plasma renin and prorenin and renin gene variation in patients with insulin-dependent diabetes mellitus and nephropathy. Nephrol Dial Transplant 1999; 14: 1904-1911. [Medline] [CrossRef]
11. Danser AH, Deinum J: Renin, prorenin and the putative (pro)renin receptor. Hypertension 2005; 46: 1069-1076. [Medline] [CrossRef]
12. Zhou A, Carrell RW, Murphy MP, Wei Z, Yan Y, Stanley PL, Stein PE, Broughton Pipkin F, Read RJ: A redox switch in angiotensinogen modulates angiotensin release. Nature 2010; 468: 108-111. [Medline] [CrossRef]
13. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 1995; 92: 3521-3525. [Medline] [CrossRef]
14. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, Murakami K: Angiotensinogen-deficient mice with hypotension. J Biol Chem 1994; 269: 31334-31337. [Medline]
15. Yanai K, Saito T, Kakinuma Y, Kon Y, Hirota K, Taniguchi-Yanai K, Nishijo N, Shigematsu Y, Horiguchi H, Kasuya Y, Sugiyama F, Yagami K, Murakami K, Fukamizu A: Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice. J Biol Chem 2000; 275: 5-8. [Medline] [CrossRef]
16. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N: Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci USA 2004; 101: 12792-12797. [Medline] [CrossRef]
17. Contrepas A, Walker J, Koulakoff A, Franek KJ, Qadri F, Giaume C, Corvol P, Schwartz CE, Nguyen G: A role of the (pro)renin receptor in neuronal cell differentiation. Am J Physiol Regul Integr Comp Physiol 2009; 297: R250-R257. [Medline] [CrossRef]
18. Ramser J, Abidi FE, Burckle CA, Lenski C, Toriello H, Wen G, Lubs HA, Engert S, Stevenson RE, Meindl A, Schwartz CE, Nguyen G: A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet 2005; 14: 1019-1027. [Medline] [CrossRef]
19. Burcklé C, Bader M: Prorenin and its ancient receptor. Hypertension 2006; 48: 549-551. [Medline] [CrossRef]
20. Ludwig J, Kerscher S, Brandt U, Pfeiffer K, Getlawi F, Apps DK, Schagger H: Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J Biol Chem 1998; 273: 10939-10947. [Medline] [CrossRef]
21. +)-ATPases - nature's most versatile proton pumps. Nat Rev Mol Cell Biol 2002; 3: 94-103. [Medline] [CrossRef]
22. Forgac M: Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 2007; 8: 917-929. [Medline] [CrossRef]
23. +-ATPase in vesicular trafficking: targeting, regulation and function. Curr Opin Cell Biol 2008; 20: 415-426. [Medline] [CrossRef]
24. Hurtado-Lorenzo A, Skinner M, El Annan J, Futai M, Sun-Wada GH, Bourgoin S, Casanova J, Wildeman A, Bechoua S, Ausiello DA, Brown D, Marshansky V: V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat Cell Biol 2006; 8: 124-136. [Medline] [CrossRef]
25. + ATPase: molecular structure and function, physiological roles and regulation. J Exp Biol 2006; 209: 577-589. [Medline] [CrossRef]
26. Sun-Wada GH, Toyomura T, Murata Y, Yamamoto A, Futai M, Wada Y: The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. J Cell Sci 2006; 119: 4531-4540. [Medline] [CrossRef]
27. Sun-Wada GH, Tabata H, Kawamura N, Futai M, Wada Y: Differential expression of a subunit isoforms of the vacuolar-type proton pump ATPase in mouse endocrine tissues. Cell Tissue Res 2007; 329: 239-248. [Medline] [CrossRef]
28. Nguyen G, Contrepas A: Physiology and pharmacology of the (pro)renin receptor. Curr Opin Pharmacol 2008; 8: 127-132. [Medline] [CrossRef]
29. Nguyen G, Muller DN: The biology of the (pro)renin receptor. J Am Soc Nephrol 2010; 21: 18-23. [Medline] [CrossRef]
30. Sihn G, Rousselle A, Vilianovitch L, Burckle C, Bader M: Physiology of the (pro)renin receptor: Wnt of change? Kidney Int 2010; 78: 246-256. [Medline] [CrossRef]
31. Advani A, Kelly DJ, Cox AJ, White KE, Advani SL, Thai K, Connelly KA, Yuen D, Trogadis J, Herzenberg AM, Kuliszewski MA, Leong-Poi H, Gilbert RE: The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension 2009; 54: 261-269. [Medline] [CrossRef]
32. Schefe JH, Neumann C, Goebel M, Danser J, Kirsch S, Gust R, Kintscher U, Unger T, Funke-Kaiser H: Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren. J Hypertens 2008; 26: 1787-1794. [Medline] [CrossRef]
33. Cousin C, Bracquart D, Contrepas A, Corvol P, Muller L, Nguyen G: Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension 2009; 53: 1077-1082. [Medline] [CrossRef]
34. Buechling T, Bartscherer K, Ohkawara B, Chaudhary V, Spirohn K, Niehrs C, Boutros M: Wnt/Frizzled signaling requires dPRR, the Drosophila homolog of the prorenin receptor. Curr Biol 2010; 20: 1263-1268. [Medline] [CrossRef]
35. Hermle T, Saltukoglu D, Grunewald J, Walz G, Simons M: Regulation of Frizzled-dependent planar polarity signaling by a V-ATPase subunit. Curr Biol 2010; 20: 1269-1276. [Medline] [CrossRef]
36. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 2006; 127: 469-480. [Medline] [CrossRef]
37. Vaccari T, Duchi S, Cortese K, Tacchetti C, Bilder D: The vacuolar ATPase is required for physiological as well as pathological activation of the Notch receptor. Development 2010; 137: 1825-1832. [Medline] [CrossRef]
38. Yan Y, Denef N, Schupbach T: The vacuolar proton pump, V-ATPase, is required for Notch signaling and endosomal trafficking in Drosophila. Dev Cell 2009; 17: 387-402. [Medline] [CrossRef]
39. Muller DN, Klanke B, Feldt S, Cordasic N, Hartner A, Schmieder RE, Luft FC, Hilgers KF: (Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertension 2008; 51: 676-681. [Medline] [CrossRef]
40. Feldt S, Maschke U, Dechend R, Luft FC, Muller DN: The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol 2008; 19: 743-748. [Medline] [CrossRef]
41. Kinouchi K, Ichihara A, Itoh H: Functional characterization of (pro)renin receptor in association with V-ATPase. Frontiers in Bioscience 2011; 1: 3216-3223